Pharm
Targeted Agents
Exam Yield
| Probability of getting 1 Question from this chapter | 90% |
| Ease of Revision | 8.61 / 10 |
Recent Questions
Questions on this chapter from recent NEET and AIIMS examinations have been about
- Trastuzumab – Overview
- Mechanism of action of imatinib
- Histone deacetylase inhibitors
- Third generation BCR-ABL kinase inhibitor
- Thalidomide is used in
- Basiliximab is
Suggested Revision
- Imatinib uses
- Sipuleucel-T
- Pembrolizumab
- Drugs used in CML
- Rituximab – Overview
- BCR-ABL kinase inhibitors
- EGFR tyrosine kinase inhibitors
- Proteasome inhibitor